• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Pixium Vision

BCI maker Science acquires retinal implant from Pixium Vision

April 25, 2024 By Sean Whooley

Brain-computer interface developer Science Corporation announced today that it acquired the IP and related assets for the Pixium Vision Prima implant. Neuralink co-founder Max Hodak founded Science, which unveiled its Science Eye brain-computer platform in 2022. The Science Eye is a visual prosthesis. It targets retinitis pigmentosa (RP) and dry age-related macular degeneration (AMD), two […]

Filed Under: Brain-Computer Interface (BCI), Business/Financial News, Featured, Health Technology, Implants, Mergers & Acquisitions, Neurological, Optical/Ophthalmic, Vision Tagged With: Pixium Vision, Science Corporation, Science Eye

Pixium Vision looks for a buyer

October 19, 2023 By Danielle Kirsh

Pixium Vision this week said it launched a tender process for the purpose of finding buyers to acquire the company’s business. The company has been unable to find financial investors within the restricted timeframe and in line with Pixium Vision’s needs. Pixium Vision is requesting the conversion of safeguard proceedings into receivership. The deadline for […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Optical/Ophthalmic Tagged With: Pixium Vision

Pixium Vision wins FDA breakthrough designation for dry AMD treatment device

March 31, 2023 By Sean Whooley

Pixium Vision announced today that it received FDA breakthrough device designation for its Prima System for partially restoring vision. The Prima System, a photovoltaic substitute of photoreceptors, provides simultaneous use of the central prosthetic and peripheral natural vision. The company designed the implant for patients with atrophic dry age-related macular degeneration (AMD). It aims to […]

Filed Under: Clinical Trials, Food & Drug Administration (FDA), Implants, Optical/Ophthalmic, Regulatory/Compliance, Vision Tagged With: Pixium Vision

MedTech 100 roundup: Industry roars back

April 12, 2021 By Sean Whooley

In the blink of an eye, the medtech industry exited its spring slump and neared its all-time best performance levels. MassDevice‘s MedTech 100 Index offered signs of a rebound last week and has built on that momentum, registering a final tally of 109.39 points on April 9. That represents a 2.9% increase from the 106.26-point mark […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Better Therapeutics, Google, Hologic, INSIGHTEC, LumiraDX, MedTech 100 Index, Medtronic, Olympus, Outset Medical, Pixium Vision, Second Sight, Varian

Second Sight, Pixium Vision merger plans are over

April 5, 2021 By Sean Whooley

Second Sight Medical notified Pixium that it decided to unilaterally terminate a memorandum of understanding (MOU) ahead of a planned merger. In a news release, Pixium said the $27.9 million private placement recently announced and closed by Second Sight was “not only explicitly prohibited under the terms of the [MOU] entered into by the companies […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Optical/Ophthalmic Tagged With: Pixium Vision, Second Sight

MedTech 100 roundup: Slight rise for the industry

March 29, 2021 By Sean Whooley

While medtech’s performance still isn’t mirroring the beginning of 2021, the industry is showing signs of life with a small improvement last week. The year’s strong start, during which MassDevice‘s MedTech 100 index notched an all-time best of 110.96 points (Feb. 15) came to an end later that month and carried over into March, with the […]

Filed Under: Business/Financial News, Diagnostics, Featured, Genomics/Molecular Diagnostics, Mergers & Acquisitions, Wall Street Beat Tagged With: 7D Surgical, Biocorp, Boston Scientific, coronavirus, COVID-19, Decision Diagnostics, Dexcom, Diabeloop, MedTech 100 Index, Personnel Moves, Pixium Vision, SeaSpine, Second Sight

DTW Podcast – CEO MacMillan on how COVID-19 strengthened Hologic

March 27, 2021 By Tom Salemi

Hologic CEO Steve MacMillan says in early March 2020 he didn’t appreciate how COVID-19 would change the world forever. But the diagnostics company quickly rose to the challenge, becoming one of the surer suppliers of diagnostic tests needed to chart the coronavirus’s severity. In this DeviceTalks Weekly podcast, MacMillan shares how Hologic pivoted to meet […]

Filed Under: Device Talks Podcasts, Diagnostics, Featured, Special Content Tagged With: Boston Scientific, DeviceTalks Weekly, GuardianLane, Hologic, Medtech Color, Medtronic, Packworld USA, Pixium Vision, Second Sight, Thermo Fisher Scientific

Second Sight’s merger with Pixium Vision may fall through

March 24, 2021 By Chris Newmarker

Second Sight‘s plans to raise $27.9 million from a private placement appear to have generated conflict with its would-be owner Pixium Vision. Pixium informed Second Sight (NSDQ: EYES)  yesterday that the private placement would breach the memorandum of understanding the two companies reached in early January, according to a Second Sight filing with the SEC. […]

Filed Under: Business/Financial News, Featured, Legal News, Mergers & Acquisitions, Neuromodulation/Neurostimulation, Optical/Ophthalmic Tagged With: Pixium Vision, Second Sight

Second Sight gains FDA nod for retinal system that may never be produced

March 5, 2021 By Nancy Crotti

Second Sight Medical  (NSDQ: EYES) today announced that the FDA has approved its Argus 2s retinal prosthesis system, but questions remain about whether it will ever be manufactured. The past year has been tough for Second Sight. The company announced in March 2020 that it would wind down its operations amid the financial shock of […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Implants, Neuromodulation/Neurostimulation, Optical/Ophthalmic, Regulatory/Compliance Tagged With: FDA, Pixium Vision, Second Sight, second-sight-medical

Pixium Vision’s novel Prima chip helps patients see the light

August 30, 2018 By Nancy Crotti

Pixium Vision said today that its Prima miniature wireless photovoltaic sub-retinal implant has been activated in the first five patients. The patients all have severe vision loss from atrophic dry age-related macular degeneration. They are enrolled in a three-year clinical study in France to evaluate the safety and function of the Prima chip in eliciting visual […]

Filed Under: Clinical Trials, Implants, Vision Tagged With: Pixium Vision

Pixium Vision touts 1st use of Prima bionic vision system

January 26, 2018 By Fink Densford

Pixium Vision (EPA:PIX) yesterday announced the first successful trial implantation and activation of its Prima next-generation miniaturized wireless photovoltaic sub-retinal implant, and that the system successfully produced visual perception. With the implantation complete, the patient will begin the re-education phase of the study which includes a six-month and 36-month follow-up, the Paris-based company said. “This first […]

Filed Under: Clinical Trials, Optical/Ophthalmic Tagged With: Pixium Vision

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy